Literature DB >> 34548655

Ibrexafungerp to treat acute vulvovaginal candidiasis.

Maria Chiara Masone1.   

Abstract

Entities:  

Mesh：

Substances：

Year:  2021        PMID： 34548655     DOI： 10.1038/s41585-021-00522-9

Source DB:  PubMed          Journal:  Nat Rev Urol        ISSN： 1759-4812            Impact factor:   14.432


× No keyword cloud information.
  1 in total

1.  Phase 2 Randomized Study of Oral Ibrexafungerp Versus Fluconazole in Vulvovaginal Candidiasis.

Authors:  Paul Nyirjesy; Jane R Schwebke; David A Angulo; Itzel A Harriott; Nkechi E Azie; Jack D Sobel
Journal:  Clin Infect Dis       Date:  2022-07-06       Impact factor: 20.999
  1 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.